Vascular endothelial growth factor (vegf) and platelet (pf-4) factor 4 inputs modulate human microvascular endothelial signaling in a three-dimensional matrix migration context

Molecular and Cellular Proteomics

Volumn 12, Issue 12, 2013, Pages 3704-3718

  Hang, Ta Chun ^a   Tedford, Nathan C ^a   Reddy, Raven J ^a   Rimchala, Tharathorn ^a   Wells, Alan ^b   White, Forest M ^a   Kamm, Roger D ^a   Lauffenburger, Douglas A ^a  

^a Massachusetts Institute of Technology   (United States)

^b UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COLLAGEN GEL; EPHRIN RECEPTOR A2; FOCAL ADHESION KINASE; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE 14; PHOSPHOTYROSINE; PROTEIN KINASE FYN; PROTEIN KINASE LYN; PROTEIN TYROSINE KINASE; THROMBOCYTE FACTOR 4; VASCULOTROPIN;

ANGIOGENESIS; ARTICLE; CELL CULTURE; CELL FUNCTION; CELL MIGRATION; CELL POLARITY; CONTROLLED STUDY; HIGH THROUGHPUT SEQUENCING; HUMAN; HUMAN CELL; MASS SPECTROMETRY; MICROVASCULAR ENDOTHELIAL CELL; MOLECULAR DYNAMICS; MOLECULAR MODEL; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; PROTEOMICS; SIGNAL TRANSDUCTION;

CELL MOVEMENT; COLLAGEN; DERMIS; ENDOTHELIAL CELLS; ENDOTHELIUM, VASCULAR; EXTRACELLULAR MATRIX; FOCAL ADHESION KINASE 1; GELS; GENE EXPRESSION REGULATION; HUMANS; MASS SPECTROMETRY; MOLECULAR SEQUENCE ANNOTATION; NEOVASCULARIZATION, PHYSIOLOGIC; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PHOSPHOTYROSINE; PLATELET FACTOR 4; PRIMARY CELL CULTURE; PROTEIN BINDING; RECEPTOR, EPHA2; SIGNAL TRANSDUCTION; SRC-FAMILY KINASES; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 84890740607     PISSN: 15359476     EISSN: 15359484     Source Type: Journal    
DOI: 10.1074/mcp.M113.030528     Document Type: Article

References (114)

1. Carmeliet, P. (2005) Angiogenesis in life, disease and medicine. Nature
2. Saharinen, P., Eklund, L., Miettinen, J., Wirkkala, R., Anisimov, A., Winderlich, M., Nottebaum, A., Vestweber, D., Deutsch, U., Koh, G. Y., Olsen, B. R., and Alitalo, K. (2008) Angiopoietins assemble distinct Tie2 signalling complexes in endothelial cell-cell and cell-matrix contacts. Nat. Cell Biol. 10, 527-537
3. Saharinen, P., Eklund, L., Miettinen, J., Wirkkala, R., Anisimov, A., Winderlich, M., Nottebaum, A., Vestweber, D., Deutsch, U., Koh, G. Y., Olsen, B. R., and Alitalo, K. (2008) Angiopoietins assemble distinct Tie2 signalling complexes in endothelial cell-cell and cell-matrix contacts. Nat. Cell Biol. 10, 527-537
4. Adair, T. H., and Montani, J.-P. (2010) Angiogenesis, Morgan & Claypool Life Sciences, San Rafael, CA
5. Yancopoulos, G. D., Davis, S., Gale, N. W., Rudge, J. S., Wiegand, S. J., and Holash, J. (2000) Vascular-specific growth factors and blood vessel formation. Nature 407, 242-248
6. Barrientos, S., Stojadinovic, O., Golinko, M. S., Brem, H., and Tomic- Canic, M. (2008) Growth factors and cytokines in wound healing. Wound Repair Regen. 16, 585-601
7. Gillitzer, R., and Goebeler, M. (2001) Chemokines in cutaneous wound healing. J. Leukoc. Biol. 69, 513-521
8. Werner, S., and Grose, R. (2003) Regulation of wound healing by growth factors and cytokines. Physiol. Rev. 83, 835-870
9. Kobayashi, H., and Lin, P. C. (2009) Angiogenesis links chronic inflammation with cancer. Methods Mol. Biol. 511, 185-191
10. Szekanecz, Z., and Koch, A. E. (2004) Vascular endothelium and immune responses: implications for inflammation and angiogenesis. Rheum. Dis. Clin. North Am. 30, 97-114
11. Kundu, J. K., and Surh, Y.-J. (2008) Inflammation: gearing the journey to cancer. Mutat. Res. 659, 15-30
12. Carmeliet, P., and Jain, R. K. (2011) Molecular mechanisms and clinical applications of angiogenesis. Nature 473, 298-307
13. Sahota, P. S., Burn, J. L., Brown, N. J., and MacNeil, S. (2004) Approaches to improve angiogenesis in tissue-engineered skin. Wound Repair Regen. 12, 635-642
14. Feil, G., Daum, L., Amend, B., Maurer, S., Renninger, M., Vaegler, M., Seibold, J., Stenzl, A., and Sievert, K.-D. (2011) From tissue engineering to regenerative medicine in urology-the potential and the pitfalls. Adv. Drug Deliv. Rev. 63, 375-378
15. Sherwood, J. K., Riley, S. L., Palazzolo, R., Brown, S. C., Monkhouse, D. C., Coates, M., Griffith, L. G., Landeen, L. K., and Ratcliffe, A. (2002) A three-dimensional osteochondral composite scaffold for articular cartilage repair. Biomaterials 23, 4739-4751
16. Ban, D.-X., Kong, X.-H., Feng, S.-Q., Ning, G.-Z., Chen, J.-T., and Guo, S.-F. (2009) Intraspinal cord graft of autologous activated Schwann cells efficiently promotes axonal regeneration and functional recovery after rat's spinal cord injury. Brain Res. 1256, 149-161
17. Hu, X., Huang, J., Ye, Z., Xia, L., Li, M., Lv, B., Shen, X., and Luo, Z. (2009) A novel scaffold with longitudinally oriented microchannels promotes peripheral nerve regeneration., Tissue Eng. 15, 3297-3308
18. Kaully, T., Kaufman-Francis, K., Lesman, A., and Levenberg, S. (2009) Vascularization-the conduit to viable engineered tissues. Tissue Eng. 15, 159-169
19. Soker, S., Machado, M., and Atala, A. (2000) Systems for therapeutic angiogenesis in tissue engineering. World J. Urol. 18, 10-18
20. Kirkpatrick, C. J., Otto, M., Van Kooten, T., Krump, V., Kriegsmann, J., and Bittinger, F. (1999) Endothelial cell cultures as a tool in biomaterial research. J. Mater. Sci. Mater. Med. 10, 589-594
21. Mendes, J. B., Campos, P. P., Ferreira, M. A. N. D., Bakhle, Y. S., and Andrade, S. P. (2007) Host response to sponge implants differs between subcutaneous and intraperitoneal sites in mice. J. Biomed. Mater. Res. 83, 408-415
22. Rimchala, T., Kamm, R. D., and Lauffenburger, D. A. (2013) Endothelial cell phenotypic behaviors cluster into dynamic state transition programs modulated by angiogenic and angiostatic cytokines. Integr. Biol. 5, 510-522
23. Bernardini, G., Ribatti, D., Spinetti, G., Morbidelli, L., Ziche, M., Santoni, A., Capogrossi, M. C., and Napolitano, M. (2003) Analysis of the role of chemokines in angiogenesis. J. Immunol. Methods 273, 83-101
24. Keeley, E. C., Mehrad, B., and Strieter, R. M. (2008) Chemokines as mediators of neovascularization. Arteriosclerosis, Thrombosis, Vasc. Biol. 28, 1928-1936
25. Mehrad, B., Keane, M. P., and Strieter, R. M. (2007) Chemokines as mediators of angiogenesis. Thromb. Haemost. 97, 755-762
26. Rosenkilde, M. M., and Schwartz, T. W. (2004) The chemokine system - a major regulator of angiogenesis in health and disease. APMIS 112, 481-495
27. Slungaard, A. (2005) Platelet factor 4: a chemokine enigma. Int. J. Biochem. Cell Biol. 37, 1162-1167
28. Aidoudi, S., and Bikfalvi, A. (2010) Interaction of PF4 (CXCL4) with the vasculature: a role in atherosclerosis and angiogenesis. Thromb. Haemost. 104, 941-948
29. Vandercappellen, J., Van Damme, J., and Struyf, S. (2011) The role of the CXC chemokines platelet factor-4 (CXCL4/PF-4) and its variant (CXCL4L1/PF-4var) in inflammation, angiogenesis and cancer. Cytokine Growth Factor Rev. 22, 1-18
30. Vandercappellen, J., Van Damme, J., and Struyf, S. (2008) The role of CXC chemokines and their receptors in cancer. Cancer Letters 267, 226-244
31. Shao, X. J., and Xie, F. M. (2005) Influence of angiogenesis inhibitors, endostatin and PF-4, on lymphangiogenesis. Lymphology 38, 1-8
32. Gupta, S. K., and Singh, J. P. (1994) Inhibition of endothelial cell proliferation by platelet factor-4 involves a unique action on S phase progression. J. Cell Biol. 127, 1121-1127
33. Sulpice, E., Contreres, J.-O., Lacour, J., Bryckaert, M., and Tobelem, G. (2004) Platelet factor 4 disrupts the intracellular signalling cascade induced by vascular endothelial growth factor by both KDR dependent and independent mechanisms. Eur. J. Biochem. 271, 3310-3318
34. Tabruyn, S. P., and Griffioen, A. W. (2007) Molecular pathways of angiogenesis inhibition. Biochem. Biophys. Res. Commun. 355, 1-5
35. Petrai, I., Rombouts, K., Lasagni, L., Annunziato, F., Cosmi, L., Romanelli, R. G., Sagrinati, C., Mazzinghi, B., Pinzani, M., Romagnani, S., Romagnani, P., and Marra, F. (2008) Activation of p38(MAPK) mediates the angiostatic effect of the chemokine receptor CXCR3-B. Int. J. Biochem. Cell Biol. 40, 1764-1774
36. Bodnar, R. J., Yates, C. C., and Wells, A. (2006) IP-10 blocks vascular endothelial growth factor-induced endothelial cell motility and tube formation via inhibition of calpain. Circulation Res. 98, 617-625
37. Bodnar, R. J., Yates, C. C., Rodgers, M. E., Du, X., and Wells, A. (2009) IP-10 induces dissociation of newly formed blood vessels. J. Cell Sci. 122, 2064-2077
38. Salcedo, R., Resau, J. H., Halverson, D., Hudson, E. A., Dambach, M., Powell, D., Wasserman, K., and Oppenheim, J. J. (2000) Differential expression and responsiveness of chemokine receptors (CXCR1-3) by human microvascular endothelial cells and umbilical vein endothelial cells. FASEB J. 14, 2055-2064
39. Chung, S., Sudo, R., Zervantonakis, I. K., Rimchala, T., and Kamm, R. D. (2009) Surface-treatment-induced three-dimensional capillary morphogenesis in a microfluidic platform., Adv. Mater. Weinheim 21, 4863-4867
40. Shults, M. D., Janes, K. A., Lauffenburger, D. A., and Imperiali, B. (2005) A multiplexed homogeneous fluorescence-based assay for protein kinase activity in cell lysates. Nat. Methods 2, 277-283
41. Zhang, Y., Wolf-Yadlin, A., and White, F. M. (2007) Quantitative proteomic analysis of phosphotyrosine-mediated cellular signaling networks. Methods Mol. Biol. 359, 203-212
42. Spangler, J. B., Neil, J. R., Abramovitch, S., Yarden, Y., White, F. M., Lauffenburger, D. A., and Wittrup, K. D. (2010) Combination antibody treatment down-regulates epidermal growth factor receptor by inhibiting endosomal recycling. Proc. Natl. Acad. Sci. U.S.A. 107, 13252-13257
43. Mortensen, P., Gouw, J. W., Olsen, J. V., Ong, S.-E., Rigbolt, K. T. G., Bunkenborg, J., Cox, J., Foster, L. J., Heck, A. J. R., Blagoev, B., Andersen, J. S., and Mann, M. (2010) MSQuant, an open source platform for mass spectrometry-based quantitative proteomics. J. Proteome Res. 9, 393-403
44. Perkins, D. N., Pappin, D. J., Creasy, D. M., and Cottrell, J. S. (1999) Probability-based protein identification by searching sequence databases using mass spectrometry data. Electrophoresis 20, 3551-3567
45. Nichols, A. M., and White, F. M. (2009) Manual validation of peptide sequence and sites of tyrosine phosphorylation from MS/MS spectra. Methods Mol. Biol. 492, 143-160
46. Naegle, K. M., Gymrek, M., Joughin, B. A., Wagner, J. P., Welsch, R. E., Yaffe, M. B., Lauffenburger, D. A., and White, F. M. (2010) PTMScout, a Web resource for analysis of high throughput post-translational proteomics studies. Mol. Cell Proteomics 9, 2558-2570
47. Kim, H.-D., Meyer, A. S., Wagner, J. P., Alford, S. K., Wells, A., Gertler, F. B., and Lauffenburger, D. A. (2011) Signaling network state predicts twist-mediated effects on breast cell migration across diverse growth factor contexts. Mol. Cell Proteomics 10, M111.008433
48. Wykosky, J., Palma, E., Gibo, D. M., Ringler, S., Turner, C. P., and Debinski, W. (2008) Soluble monomeric EphrinA1 is released from tumor cells and is a functional ligand for the EphA2 receptor. Oncogene 27, 7260-7273
49. Miao, H., Li, D.-Q., Mukherjee, A., Guo, H., Petty, A., Cutter, J., Basilion, J. P., Sedor, J., Wu, J., Danielpour, D., Sloan, A. E., Cohen, M. L., and Wang, B. (2009) EphA2 mediates ligand-dependent inhibition and ligand-independent promotion of cell migration and invasion via a reciprocal regulatory loop with Akt. Cancer Cell 16, 9-20
50. Walker-Daniels, J., Riese, D. J., and Kinch, M. S. (2002) c-Cbl-dependent EphA2 protein degradation is induced by ligand binding. Mol. Cancer Res. 1, 79-87
51. Pasquale, E. B. (2010) Eph receptors and ephrins in cancer: bidirectional signalling and beyond. Nat. Rev. Cancer 10, 165-180
52. Kikawa, K. D., Vidale, D. R., Van Etten, R. L., and Kinch, M. S. (2002) Regulation of the EphA2 kinase by the low molecular weight tyrosine phosphatase induces transformation. J. Biol. Chem. 277, 39274-39279
53. Beauchamp, A., and Debinski, W. (2012) Ephs and ephrins in cancer: Ephrin-A1 signalling. Semin. Cell Develop. Biol. 23, 109-115
54. Noberini, R., Koolpe, M., Peddibhotla, S., Dahl, R., Su, Y., Cosford, N. D. P., Roth, G. P., and Pasquale, E. B. (2008) Small molecules can selectively inhibit ephrin binding to the EphA4 and EphA2 receptors. J. Biol. Chem. 283, 29461-29472
55. Noberini, R., Lamberto, I., and Pasquale, E. B. (2011) Targeting Eph receptors with peptides and small molecules: Progress and challenges. Semin. Cell Develop. Biol. 23, 51-57
56. Dephoure, N., Zhou, C., Villén, J., Beausoleil, S. A., Bakalarski, C. E., Elledge, S. J., and Gygi, S. P. (2008) A quantitative atlas of mitotic phosphorylation. Proc. Natl. Acad. Sci. U.S.A. 105, 10762-10767
57. Platt, M. O., Wilder, C. L., Wells, A., Griffith, L. G., and Lauffenburger, D. A. (2009) Multipathway kinase signatures of multipotent stromal cells are predictive for osteogenic differentiation: tissue-specific stem cells. Stem Cells 27, 2804-2814
58. Kanaji, N., Nelson, A., Allen-Gipson, D. S., Sato, T., Nakanishi, M., Wang, X., Li, Y., Basma, H., Michalski, J., Farid, M., Rennard, S. I., and Liu, X. (2012) The p38 mitogen-activated protein kinases modulate endothelial cell survival and tissue repair. Inflamm. Res. 61, 233-244
59. Raingeaud, J., Gupta, S., Rogers, J. S., Dickens, M., Han, J., Ulevitch, R. J., and Davis, R. J. (1995) Pro-inflammatory cytokines and environmental stress cause p38 mitogen-activated protein kinase activation by dual phosphorylation on tyrosine and threonine. J. Biol. Chem. 270, 7420-7426
60. Roux, P. P., and Blenis, J. (2004) ERK and p38 MAPK-activated protein kinases: a family of protein kinases with diverse biological functions. Microbiol. Mol. Biol. Rev. 68, 320-344
61. Zhang, Y.-Y., Mei, Z.-Q., Wu, J.-W., and Wang, Z.-X. (2008) Enzymatic activity and substrate specificity of mitogen-activated protein kinase p38alpha in different phosphorylation states. J. Biol. Chem. 283, 26591-26601
62. Werdich, X. Q., and Penn, J. S. (2005) Src, Fyn and Yes play differential roles in VEGF-mediated endothelial cell events. Angiogenesis 8, 315-326
63. Zhao, X., and Guan, J.-L. (2011) Focal adhesion kinase and its signaling pathways in cell migration and angiogenesis. Adv. Drug Deliv. Rev. 63, 610-615
64. Calalb, M. B., Polte, T. R., and Hanks, S. K. (1995) Tyrosine phosphorylation of focal adhesion kinase at sites in the catalytic domain regulates kinase activity: a role for Src family kinases. Mol. Cell. Biol. 15, 954-963
65. Matsui, H., Harada, I., and Sawada, Y. (2012) Src, p130Cas, and mechanotransduction in cancer cells. Genes Cancer 3, 394-401
66. Kawauchi, K., Tan, W. W., Araki, K., Abu Bakar, F. B., Kim, M., Fujita, H., Hirata, H., and Sawada, Y. (2012) p130Cas-dependent actin remodelling regulates myogenic differentiation. Biochem. J. 445, 323-332
67. George, B., Verma, R., Soofi, A. A., Garg, P., Zhang, J., Park, T.-J., Giardino, L., Ryzhova, L., Johnstone, D. B., Wong, H., Nihalani, D., Salant, D. J., Hanks, S. K., Curran, T., Rastaldi, M. P., and Holzman, L. B. (2012) Crk1/2-dependent signaling is necessary for podocyte foot process spreading in mouse models of glomerular disease. J. Clin. Invest. 122, 674-692
68. Liu, G., Place, A. T., Chen, Z., Brovkovych, V. M., Vogel, S. M., Muller, W. A., Skidgel, R. A., Malik, A. B., and Minshall, R. D. (2012) ICAM-1-activated Src and eNOS signaling increase endothelial cell surface PECAM-1 adhesivity and neutrophil transmigration. Blood 120, 1942-1952
69. Fujiwara, K., Masuda, M., Osawa, M., Kano, Y., and Katoh, K. (2001) Is PECAM-1 a mechanoresponsive molecule? Cell Struct. Funct. 26, 11-17
70. Newman, P. J., and Newman, D. K. (2003) Signal transduction pathways mediated by PECAM-1: new roles for an old molecule in platelet and vascular cell biology. Arteriosclerosis, Thrombosis, Vasc. Biol. 23, 953-964
71. Jackson, D. E. (2003) The unfolding tale of PECAM-1. FEBS Lett. 540, 7-14
72. Chiu, Y.-J., McBeath, E., and Fujiwara, K. (2008) Mechanotransduction in an extracted cell model: Fyn drives stretch- and flow-elicited PECAM-1 phosphorylation. J. Cell Biol. 182, 753-763
73. Perretti, M., and Dalli, J. (2009) Exploiting the Annexin A1 pathway for the development of novel anti-inflammatory therapeutics. Br. J. Pharmacol. 158, 936-946
74. Yi, M., and Schnitzer, J. E. (2009) Impaired tumor growth, metastasis, angiogenesis and wound healing in annexin A1-null mice., Proc. Natl. Acad. Sci. U.S.A. 106, 17886-17891
75. Lim, L. H. K., and Pervaiz, S. (2007) Annexin 1: the new face of an old molecule. FASEB J. 21,968-975
76. Frey, B. M., Reber, B. F., Vishwanath, B. S., Escher, G., and Frey, F. J. (1999) Annexin I modulates cell functions by controlling intracellular calcium release. FASEB J. 13, 2235-2245
77. Vindis, C., Cerretti, D. P., Daniel, T. O., and Huynh-Do, U. (2003) EphB1 recruits c-Src and p52Shc to activate MAPK/ERK and promote chemotaxis. J. Cell Biol. 162, 661-671
78. Ravichandran, K. S. (2001) Signaling via Shc family adapter proteins. Oncogene 20, 6322-6330
79. Matozaki, T., Murata, Y., Saito, Y., Okazawa, H., and Ohnishi, H. (2009) Protein tyrosine phosphatase SHP-2: a proto-oncogene product that promotes Ras activation. Cancer Sci. 100, 1786-1793
80. Brantley-Sieders, D. M., Caughron, J., Hicks, D., Pozzi, A., Ruiz, J. C., and Chen, J. (2004) EphA2 receptor tyrosine kinase regulates endothelial cell migration and vascular assembly through phosphoinositide 3-kinase-mediated Rac1 GTPase activation. J. Cell Sci. 117, 2037-2049
81. Campbell, T. N., and Robbins, S. M. (2008) The Eph receptor/ephrin system: an emerging player in the invasion game. Curr. Issues Mol. Biol. 10, 61-66
82. Poliakov, A., Cotrina, M., and Wilkinson, D. G. (2004) Diverse roles of eph receptors and ephrins in the regulation of cell migration and tissue assembly. Dev. Cell 7, 465-480
83. Cheng, N., Brantley, D. M., Liu, H., Lin, Q., Enriquez, M., Gale, N., Yancopoulos, G., Cerretti, D. P., Daniel, T. O., and Chen, J. (2002) Blockade of EphA receptor tyrosine kinase activation inhibits vascular endothelial cell growth factor-induced angiogenesis. Mol. Cancer Res. 1, 2-11
84. Kasper, B., and Petersen, F. (2011) Molecular pathways of platelet factor 4/CXCL4 signaling. Eur. J. Cell Biol. 90, 521-526
85. Larsen, A. B., Pedersen, M. W., Stockhausen, M.-T., Grandal, M. V., van Deurs, B., and Poulsen, H. S. (2007) Activation of the EGFR gene target EphA2 inhibits epidermal growth factor-induced cancer cell motility. Mol. Cancer Res. 5, 283-293
86. Hendrix, M. J. C., Seftor, E. A., Hess, A. R., and Seftor, R. E. B. (2003) Vasculogenic mimicry and tumour-cell plasticity: lessons from melanoma. Nat Rev Cancer 3, 411-421
87. Hess, A. R., Seftor, E. A., Gruman, L. M., Kinch, M. S., Seftor, R. E. B., and Hendrix, M. J. C. (2006) VE-cadherin regulates EphA2 in aggressive melanoma cells through a novel signaling pathway: implications for vasculogenic mimicry. Cancer Biol. Ther. 5, 228-233
88. Miao, H., Burnett, E., Kinch, M., Simon, E., and Wang, B. (2000) Activation of EphA2 kinase suppresses integrin function and causes focal-adhesion-kinase dephosphorylation. Nat Cell Biol. 2, 62-69
89. Miao, H., and Wang, B. (2012) EphA receptor signaling-Complexity and emerging themes. Semin. Cell Develop. Biol. 23, 16-25
90. Radke, S., Austermann, J., Russo-Marie, F., Gerke, V., and Rescher, U. (2004) Specific association of annexin 1 with plasma membrane-resident and internalized EGF receptors mediated through the protein core domain. FEBS Lett. 578, 95-98
91. Tcatchoff, L., Andersson, S., Utskarpen, A., Klokk, T. I., Skånland, S. S., Pust, S., Gerke, V., and Sandvig, K. (2012) Annexin A1 and A2: roles in retrograde trafficking of Shiga toxin. PLoS ONE 7, e40429
92. Anastasiadis, P. Z., and Reynolds, A. B. (2000) The p120 catenin family: complex roles in adhesion, signaling and cancer. J. Cell Sci. 113, 1319-1334
93. Hu, G. (2012) p120-Catenin: a novel regulator of innate immunity and inflammation. Crit. Rev. Immunol. 32, 127-138
94. Potapova, T. A., Daum, J. R., Byrd, K. S., and Gorbsky, G. J. (2009) Fine tuning the cell cycle: activation of the Cdk1 inhibitory phosphorylation pathway during mitotic exit. Mol. Biol. Cell 20, 1737-1748
95. Welburn, J. P. I., Tucker, J. A., Johnson, T., Lindert, L., Morgan, M., Willis, A., Noble, M. E. M., and Endicott, J. A. (2007) How tyrosine 15 phosphorylation inhibits the activity of cyclin-dependent kinase 2-cyclin A. J. Biol. Chem. 282, 3173-3181
96. Squire, C. J., Dickson, J. M., Ivanovic, I., and Baker, E. N. (2005) Structure and inhibition of the human cell cycle checkpoint kinase, Wee1A kinase: an atypical tyrosine kinase with a key role in CDK1 regulation. Structure 13, 541-550
97. Mayya, V., Rezual, K., Wu, L., Fong, M. B., and Han, D. K. (2006) Absolute quantification of multisite phosphorylation by selective reaction monitoring mass spectrometry: determination of inhibitory phosphorylation status of cyclin-dependent kinases. Mol. Cell. Proteomics 5, 1146-1157
98. Norbury, C., Blow, J., and Nurse, P. (1991) Regulatory phosphorylation of the p34cdc2 protein kinase in vertebrates. EMBO J. 10, 3321-3329
99. Lee, K., Deng, X., and Friedman, E. (2000) Mirk protein kinase is a mitogen-activated protein kinase substrate that mediates survival of colon cancer cells. Cancer Res. 60, 3631-3637
100. Fang, W. B., Brantley-Sieders, D. M., Hwang, Y., Ham, A.-J. L., and Chen, J. (2008) Identification and functional analysis of phosphorylated tyrosine residues within EphA2 receptor tyrosine kinase. J. Biol. Chem. 283, 16017-16026
101. Balasubramaniam, D., Paul, L. N., Homan, K. T., Hall, M. C., and Stauffacher, C. V. (2011) Specificity of HCPTP variants toward EphA2 tyrosines by quantitative selected reaction monitoring. Protein Sci. 20, 1172-1181
102. Thalhammer, A., Trinidad, J. C., Burlingame, A. L., and Schoepfer, R. (2009) Densin-180: revised membrane topology, domain structure and phosphorylation status. J. Neurochem. 109, 297-302
103. Eminaga, S., and Bennett, A. M. (2008) Noonan syndrome-associated SHP-2/Ptpn11 mutants enhance SIRPalpha and PZR tyrosyl phosphorylation and promote adhesion-mediated ERK activation. J. Biol. Chem. 283, 15328-15338
104. Romanova, L. Y., Hashimoto, S., Chay, K.-O., Blagosklonny, M. V., Sabe, H., and Mushinski, J. F. (2004) Phosphorylation of paxillin tyrosines 31 and 118 controls polarization and motility of lymphoid cells and is PMA-sensitive. J. Cell Sci. 117, 3759-3768
105. Tsubouchi, A., Sakakura, J., Yagi, R., Mazaki, Y., Schaefer, E., Yano, H., and Sabe, H. (2002) Localized suppression of RhoA activity by Tyr31/118-phosphorylated paxillin in cell adhesion and migration. J. Cell Biol. 159, 673-683
106. Ren, Y., Chen, Z., Chen, L., Fang, B., Win-Piazza, H., Haura, E., Koomen, J. M., and Wu, J. (2010) Critical role of Shp2 in tumor growth involving regulation of c-Myc. Genes Cancer 1, 994-1007
107. Huang, P. H., Mukasa, A., Bonavia, R., Flynn, R. A., Brewer, Z. E., Cavenee, W. K., Furnari, F. B., and White, F. M. (2007) Quantitative analysis of EGFRvIII cellular signaling networks reveals a combinatorial therapeutic strategy for glioblastoma. Proc. Natl. Acad. Sci. U.S.A. 104, 12867-12872
108. Su, J., Yang, L. T., and Sap, J. (1996) Association between receptor protein-tyrosine phosphatase RPTPalpha and the Grb2 adaptor. Dual Src homology (SH) 2/SH3 domain requirement and functional consequences. J. Biol. Chem. 271, 28086-28096
109. Tremper-Wells, B., Resnick, R. J., Zheng, X., Holsinger, L. J., and Shalloway, D. (2010) Extracellular domain dependence of PTPalpha transforming activity. Genes Cells 15, 711-724
110. O'Meara, R. W., Michalski, J.-P., and Kothary, R. (2011) Integrin signaling in oligodendrocytes and its importance in CNS myelination. J. Signal Transduct. 2011:354091
111. Shikata, Y., Birukov, K. G., Birukova, A. A., Verin, A., and Garcia, J. G. N. (2003) Involvement of site-specific FAK phosphorylation in sphingosine-1 phosphate- and thrombin-induced focal adhesion remodeling: role of Src and GIT. FASEB J. 17, 2240-2249
112. Patrussi, L., Ulivieri, C., Lucherini, O. M., Paccani, S. R., Gamberucci, A., Lanfrancone, L., Pelicci, P. G., and Baldari, C. T. (2007) p52Shc is required for CXCR4-dependent signaling and chemotaxis in T cells. Blood 110, 1730-1738
113. Sotirellis, N., Johnson, T. M., Hibbs, M. L., Stanley, I. J., Stanley, E., Dunn, A. R., and Cheng, H. C. (1995) Autophosphorylation induces autoactivation and a decrease in the Src homology 2 domain accessibility of the Lyn protein kinase. J. Biol. Chem. 270, 29773-29780
114. Vizcaíno, J. A., Côté , R. G., Csordas, A., Dianes, J. A., Fabregat, A., Foster, J. M., Griss, J., Alpi, E., Birim, M., Contell, J., O'Kelly, G., Schoenegger, A., Ovelleiro, D., Pérez-Riverol, Y., Reisinger, F., Ríos, D., Wang, R., and Hermjakob, H. (2013) The PRoteomics IDEntifications (PRIDE) database and associated tools: status in 2013. Nucleic Acids Res. 41, D1063-D1069